GenMark Diagnostics, Inc
GNMK
GNMK was delisted on the 21st of April, 2021.
164 hedge funds and large institutions have $1.62B invested in GenMark Diagnostics, Inc in 2021 Q1 according to their latest regulatory filings, with 62 funds opening new positions, 29 increasing their positions, 59 reducing their positions, and 48 closing their positions.
53% more capital invested
Capital invested by funds: $1.06B → $1.62B (+$560M)
45% more call options, than puts
Call options by funds: $4.51M | Put options by funds: $3.11M
29% more first-time investments, than exits
New positions opened: 62 | Existing positions closed: 48
9% more funds holding
Funds holding: 151 → 164 (+13)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
51% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 59
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$80.8M |
| 2 |
JP Morgan Chase
New York
|
+$55.5M |
| 3 |
VI
Versor Investments
New York
|
+$49.5M |
| 4 |
TAL
TIG Advisors LLC
New York
|
+$33M |
| 5 |
Millennium Management
New York
|
+$32.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$198M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$65.4M |
| 3 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$38.1M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$31.4M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$25.3M |
GNMK Hedge Fund Activity: Q1 2021 in Review
164 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q1 2021, worth a combined $1.62B — up 53% from $1.06B a quarter earlier.
Buyers outnumbered sellers: 62 funds opened new GNMK positions and 48 closed out — a net gain of 14 holders — while 29 added to existing stakes and 59 trimmed.
The largest buyer was Magnetar Financial, opening a new position worth an estimated $80.8M. The largest seller was Fidelity Investments, cutting an estimated $198M.
- 164 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q1 2021, up from 151 in Q4 2020.
- Funds reported $1.62B of GenMark Diagnostics, Inc stock for Q1 2021, up 53% quarter-over-quarter.
- 62 funds opened new GenMark Diagnostics, Inc positions in Q1 2021 and 48 closed out, a net change of +14 holders.
- The largest GenMark Diagnostics, Inc buyer in Q1 2021 was Magnetar Financial, an estimated $80.8M added.
- The largest GenMark Diagnostics, Inc seller in Q1 2021 was Fidelity Investments, an estimated $198M sold.
Based on aggregated 13F filings for Q1 2021.